Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Expert Opinion on Therapeutic Targets|July 5, 2005
The emerging utility of animal models of chronic neurodegenerative diseasesP J Kahle, C Haass
Annals of the New York Academy of Sciences|February 24, 2001
Physiology and pathophysiology of alpha-synuclein. Cell culture and transgenic animal models based on a Parkinson's disease-associated proteinP J Kahle, M Neumann, L Ozmen, et al.
Journal of Neurochemistry|May 22, 2001
Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic miceS Rathke-Hartlieb, P J Kahle, M Neumann, et al.
The Journal of Biological Chemistry|January 5, 2000
Constitutive phosphorylation of the Parkinson's disease associated alpha-synucleinM Okochi, J Walter, A Koyama, et al.
Neuroreport|December 16, 2000
Lewy body variant of Alzheimer's disease: alpha-synuclein in dystrophic neurites of A beta plaquesO Wirths, S Weickert, K Majtenyi, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1996
The molecular significance of amyloid beta-peptide for Alzheimer's diseaseC Haass
European Archives of Psychiatry and Clinical Neuroscience|February 2, 2000
The biological and pathological function of presenilin proteins--simple cell systems and a worm in Alzheimer's disease researchC Haass, R Baumeister
Journal of Molecular Neuroscience : MN|January 31, 2002
Nuclear signaling: a common function of presenilin substrates?H Steiner, C Haass
Pageof 12